Martha J. Demski - 22 May 2024 Form 4 Insider Report for Equillium, Inc. (EQ)

Reporting relationship: Director
Issuer ticker: EQ
Reported as of: 22 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 May 2024, 18:04:25 UTC
Prior SEC filing: 05 Sep 2023
Next SEC filing: 21 Jun 2024
Source filing: View source filing
Reporting owner signature: Jason A. Keyes, Attorney-in-Fact for Martha J. Demski

Key filing fact

Martha J. Demski filed Form 4 for Equillium, Inc. (EQ) on 23 May 2024.

Key facts

This page summarizes Martha J. Demski's Form 4 filing for Equillium, Inc. (EQ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 May 2024, 18:04.

Change

Previous filing in this sequence was filed on 05 Sep 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EQ transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +20,000
Change %
Price: $0.000000
Shares after: 20,000
Date: 22 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $1.43
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.